Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 2
2012 1
2013 1
2014 4
2015 8
2016 7
2017 1
2018 5
2019 3
2020 3
2021 10
2022 10
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies.
Aiello A, Coppola A, Ruggieri S, Farroni C, Altera AMG, Salmi A, Vanini V, Cuzzi G, Petrone L, Meschi S, Lapa D, Bettini A, Haggiag S, Prosperini L, Galgani S, Quartuccio ME, Bevilacqua N, Garbuglia AR, Agrati C, Puro V, Tortorella C, Gasperini C, Nicastri E, Goletti D. Aiello A, et al. Among authors: vanini v. J Neurol Neurosurg Psychiatry. 2023 Apr;94(4):290-299. doi: 10.1136/jnnp-2022-330175. Epub 2022 Dec 15. J Neurol Neurosurg Psychiatry. 2023. PMID: 36522154 Free PMC article.
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose.
Ruggieri S, Aiello A, Tortorella C, Navarra A, Vanini V, Meschi S, Lapa D, Haggiag S, Prosperini L, Cuzzi G, Salmi A, Quartuccio ME, Altera AMG, Garbuglia AR, Ascoli Bartoli T, Galgani S, Notari S, Agrati C, Puro V, Nicastri E, Gasperini C, Goletti D. Ruggieri S, et al. Among authors: vanini v. Int J Mol Sci. 2023 May 10;24(10):8525. doi: 10.3390/ijms24108525. Int J Mol Sci. 2023. PMID: 37239872 Free PMC article.
Multicenter analysis of sputum microbiota in tuberculosis patients.
Sala C, Benjak A, Goletti D, Banu S, Mazza-Stadler J, Jaton K, Busso P, Remm S, Leleu M, Rougemont J, Palmieri F, Cuzzi G, Butera O, Vanini V, Kabir S, Rahman SMM, Nicod L, Cole ST. Sala C, et al. Among authors: vanini v. PLoS One. 2020 Oct 12;15(10):e0240250. doi: 10.1371/journal.pone.0240250. eCollection 2020. PLoS One. 2020. PMID: 33044973 Free PMC article.
Host biomarker-based quantitative rapid tests for detection and treatment monitoring of tuberculosis and COVID-19.
Pierneef L, van Hooij A, de Jong D, Tjon Kon Fat EM, van Meijgaarden KE, Petruccioli E, Vanini V, Roukens AHE, Goletti D, Corstjens PLAM, Joosten SA, Geluk A; BEAT-COVID study group. Pierneef L, et al. Among authors: vanini v. iScience. 2023 Jan 20;26(1):105873. doi: 10.1016/j.isci.2022.105873. Epub 2022 Dec 26. iScience. 2023. PMID: 36590898 Free PMC article.
Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2.
Petrone L, Petruccioli E, Vanini V, Cuzzi G, Gualano G, Vittozzi P, Nicastri E, Maffongelli G, Grifoni A, Sette A, Ippolito G, Migliori GB, Palmieri F, Goletti D. Petrone L, et al. Among authors: vanini v. Int J Infect Dis. 2021 Dec;113 Suppl 1:S82-S87. doi: 10.1016/j.ijid.2021.02.090. Epub 2021 Mar 10. Int J Infect Dis. 2021. PMID: 33713816 Free PMC article.
In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy.
Petrone L, Petruccioli E, Alonzi T, Vanini V, Cuzzi G, Najafi Fard S, Castilletti C, Palmieri F, Gualano G, Vittozzi P, Nicastri E, Lepore L, Grifoni A, Antinori A, Vergori A, Ippolito G, Cantini F, Goletti D. Petrone L, et al. Among authors: vanini v. J Infect. 2021 Apr;82(4):58-66. doi: 10.1016/j.jinf.2021.02.023. Epub 2021 Feb 25. J Infect. 2021. PMID: 33639176 Free PMC article.
Humoral and Cellular Response to Spike of Delta SARS-CoV-2 Variant in Vaccinated Patients With Multiple Sclerosis.
Petrone L, Tortorella C, Aiello A, Farroni C, Ruggieri S, Castilletti C, Meschi S, Cuzzi G, Vanini V, Palmieri F, Prosperini L, Haggiag S, Galgani S, Grifoni A, Sette A, Gasperini C, Nicastri E, Goletti D. Petrone L, et al. Among authors: vanini v. Front Neurol. 2022 May 31;13:881988. doi: 10.3389/fneur.2022.881988. eCollection 2022. Front Neurol. 2022. PMID: 35711277 Free PMC article.
56 results